Find clinical trials for Prostate Cancer in Pittsburgh, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Pittsburgh, PA, USA:
The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...
Phase 2
Pittsburgh, Pennsylvania, United States and 22 other locations
A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 22 other locations
the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...
Pittsburgh, Pennsylvania, United States and 28 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Pittsburgh, Pennsylvania, United States and 50 other locations
to as AAA617. The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate...
Phase 4
Pittsburgh, Pennsylvania, United States and 53 other locations
enzalutamide or abiraterone/prednisone alone in asymptomatic or mildly symptomatic subjects with progressive, metastatic castration-resistant prostate...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 23 other locations
of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...
Phase 2
Pittsburgh, Pennsylvania, United States and 25 other locations
has in treatment of patients with metastatic castrate resistant prostate cancer (mCRPC).The hypothesis for this trial is that caboz...
Phase 2
Pittsburgh, Pennsylvania, United States and 4 other locations
therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Coho...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 27 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Pittsburgh, Pennsylvania, United States and 388 other locations
Clinical trials
Research sites
Resources
Legal